Ignite Creation Date:
2025-12-24 @ 11:02 PM
Ignite Modification Date:
2026-02-22 @ 5:08 PM
Study NCT ID:
NCT00509769
Status:
COMPLETED
Last Update Posted:
2013-04-02
First Post:
2007-07-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Trastuzumab Emtansine (Trastuzumab-MCC-DM1) Administered Intravenously to Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer
Sponsor:
Genentech, Inc.
Organization: